Projects per year
Abstract
Myc controls the metabolic reprogramming that supports effector T cell differentiation. The expression of Myc is regulated by the T cell antigen receptor (TCR) and pro-inflammatory cytokines such as interleukin-2 (IL-2). We now show that the TCR is a digital switch for Myc mRNA and protein expression that allows the strength of the antigen stimulus to determine the frequency of T cells that express Myc. IL-2 signalling strength also directs Myc expression but in an analogue process that fine-tunes Myc quantity in individual cells via post-transcriptional control of Myc protein. Fine-tuning Myc matters and is possible as Myc protein has a very short half-life in T cells due to its constant phosphorylation by glycogen synthase kinase 3 (GSK3) and subsequent proteasomal degradation. We show that Myc only accumulates in T cells exhibiting high levels of amino acid uptake allowing T cells to match Myc expression to biosynthetic demands. The combination of digital and analogue processes allows tight control of Myc expression at the population and single cell level during immune responses.
Original language | English |
---|---|
Pages (from-to) | 2008-2024 |
Number of pages | 17 |
Journal | EMBO Journal |
Volume | 34 |
Issue number | 15 |
DOIs | |
Publication status | Published - 4 Aug 2015 |
Keywords
- Cytokine signals
- Metabolism
- Myc
- T lymphocytes
- TCR signals
ASJC Scopus subject areas
- Molecular Biology
- General Biochemistry,Genetics and Molecular Biology
- General Immunology and Microbiology
- General Neuroscience
Fingerprint
Dive into the research topics of 'Single cell tuning of Myc expression by antigen receptor signal strength and interleukin-2 in T lymphocytes'. Together they form a unique fingerprint.Projects
- 5 Finished
-
How Does O-GlcNAc Transferase Integrate Glucose and Glutamine Metabolism to Control Cytotoxic T Lymphocyte Function?
Cantrell, D. (Investigator)
1/01/16 → 30/06/17
Project: Research
-
Investigating MRNA Methyl Cap Regulation, Function and Therapeutic Potential (Senior Non-Clinical Fellowship)
Cowling, V. (Investigator)
1/01/14 → 31/12/21
Project: Research
-
Strategic Award: Wellcome Trust Technology Platform
Blow, J. (Investigator), Lamond, A. (Investigator) & Owen-Hughes, T. (Investigator)
1/01/13 → 30/09/18
Project: Research
Profiles
-
Cantrell, Doreen
- Cell Signalling and Immunology - Wellcome Trust Principal Research Fellow of Immunology
Person: Academic